ⅠA期肺腺癌患者发生气腔播散的预后及危险因素分析

张炎 ,  陈宽冰 ,  吴雅楠

中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (7) : 600 -603.

PDF (414KB)
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (7) : 600 -603. DOI: 10.12007/j.issn.0258‐4646.2026.07.005
论著

ⅠA期肺腺癌患者发生气腔播散的预后及危险因素分析

作者信息 +

Analysis of prognosis and risk factors for spread through air spaces in patients with stageⅠA lung adenocarcinoma

Author information +
文章历史 +
PDF (423K)

摘要

目的 探讨ⅠA期肺腺癌患者气腔播散 (STAS) 的预后及危险因素。方法 收集2017年9月至2019年12月间中国医科大学附属盛京医院收治的374例ⅠA期肺腺癌患者的临床资料,根据病理诊断结果分为STAS阳性组 (n = 88) 和STAS阴性组 (n = 286)。采用Kaplan-Meier法绘制生存曲线,使用单因素及二元logistic回归分析ⅠA期肺腺癌患者STAS发生的危险因素。结果 STAS阳性组患者的中位总生存期 (OS) 为79个月,STAS阴性组患者的中位OS为96个月,STAS阳性组OS显著低于STAS阴性组 (P < 0.001)。2组性别、体重指数 (BMI)、吸烟史、肺腺癌亚型和肿瘤实性成分占比 (CTR) 比较差异有统计学意义 (P < 0.05)。二元logistic回归分析结果显示,BMI、吸烟史、肺腺癌亚型和CTR是发生STAS的独立危险因素 (P < 0.05)。结论 发生STAS的ⅠA期肺腺癌患者预后较差。对于有吸烟史、CTR和BMI较高及病理类型乳头型为主要特征的ⅠA期肺腺癌患者,需警惕存在STAS风险。

Abstract

Objective To investigate the prognosis and risk factors for spread through air spaces (STAS) in patients with stageⅠA lung adenocarcinoma. Methods Clinical data of 374 patients with stageⅠA lung adenocarcinoma admitted to Shengjing Hospital of China Medical University from September 2017 to December 2019 were collected. Patients were divided into the STAS-positive group (n = 88) and the STAS-negative group (n = 286) based on pathological diagnosis. The Kaplan-Meier method was used to plot survival curves,and univariate and binary logistic regression analyses were performed to identify risk factors for STAS in patients with stageⅠA lung adenocarcinoma. Results The median overall survival (OS) of patients in the STAS-positive group was 79 months,whereas the median OS of patients in the STAS-negative group was 96 months,with OS being significantly lower in the STAS-positive group (P < 0.001). There were statistically significant differences between the two groups in terms of sex,body mass index (BMI),smoking history,lung adenocarcinoma subtype,and consolidation tumor ratio (CTR) (P < 0.05). Binary logistic regression analysis showed that BMI,smoking history,lung adenocarcinoma subtype,and CTR were independent risk factors for STAS (P < 0.05). Conclusion Patients with stageⅠA lung adenocarcinoma and STAS have a poorer prognosis. In patients with stageⅠA lung adenocarcinoma,smoking history,high CTR,high BMI,and papillary-predominant pathological subtype are associated with an increased risk of STAS.

关键词

肺腺癌 / 气腔播散 / 乳头型 / 肿瘤实性成分占比 / 预后

Key words

lung adenocarcinoma / spread through air spaces / papillary / consolidation tumor ratio / prognosis

引用本文

引用格式 ▾
张炎,陈宽冰,吴雅楠. ⅠA期肺腺癌患者发生气腔播散的预后及危险因素分析[J]. 中国医科大学学报, 2026, 55(7): 600-603 DOI:10.12007/j.issn.0258‐4646.2026.07.005

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

THAI AA,SOLOMON BJ,SEQUIST LV,et al. Lung cancer. [J]. Lancet,2021,398 (10299):535-554. DOI:10.1016/S0140-6736(21)00312-3.

[2]

JHA SK,DE RUBIS G,DEVKOTA SR,et al. Cellular senescence in lung cancer:molecular mechanisms and therapeutic interventions [J]. Ageing Res Rev,2024,97:102315. DOI:10.1016/j.arr.2024.102315.

[3]

HE BZ,ZHAO XY,PU Y,et al. Trends and projection of burden on lung cancer and risk factors in China from 1990 to 2060 [J]. Thorac Cancer,2024,15 (22):1688-1704. DOI:10.1111/1759-7714.15332.

[4]

KWAK SH,KIM CY,LEE SH,et al. Updates on lung cancer screening for early detection [J]. Korean J Intern Med,2025,40 (4):546-556. DOI:10.3904/kjim.2025.008.

[5]

OUDKERK M,LIU SY,HEUVELMANS MA,et al. Lung cancer LDCT screening and mortality reduction:evidence,pitfalls and future perspectives [J]. Nat Rev Clin Oncol,2021,18:135-151. DOI:10.1038/s41571-020-00432-6.

[6]

DENG CQ,ZHENG Q,ZHANG Y,et al. Validation of the novel international association for the study of lung cancer grading system for invasive pulmonary adenocarcinoma and association with common driver mutations [J]. J Thorac Oncol,2021,16 (10):1684-1693. DOI:10.1016/j.jtho.2021.07.006.

[7]

TRAVIS WD,BRAMBILLA E,NICHOLSON AG,et al. The 2015 World Health Organization classification of lung tumors:impact of genetic,clinical and radiologic advances since the 2004 classification [J]. J Thorac Oncol,2015,10 (9):1243-1260. DOI:10.1097/JTO.0000000000000630.

[8]

IKEDA T,KADOTA K,GO T,et al. Current status and perspectives of spread through air spaces in lung cancer [J]. Thorac Cancer,2021,12 (11):1639-1646. DOI:10.1111/1759-7714.13918.

[9]

KADOTA K,NITADORI JI,SIMA CS,et al. Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage Ⅰlung adenocarcinomas [J]. J Thorac Oncol,2015,10 (5):806-814. DOI:10.1097/JTO.0000000000000486.

[10]

TOYOKAWA G,YAMADA Y,TAGAWA T,et al. Significance of spread through air spaces in resected pathological stage I lung adenocarcinoma [J]. Ann Thorac Surg,2018,105 (6):1655-1663. DOI:10.1016/j.athoracsur.2018.01.037.

[11]

DING Y,CHEN YY,WEN H,et al. Pretreatment prediction of tumour spread through air spaces in clinical stageⅠnon-small-cell lung cancer [J]. Eur J Cardiothorac Surg,2022,62 (3):ezac248. DOI:10.1093/ejcts/ezac248.

[12]

周树德,张晋源,李小强. 气腔播散对非小细胞肺癌术后患者预后影响的荟萃分析 [J]. 肿瘤综合治疗电子杂志,2025,11 (4):62-73. DOI:10.12151/JMCM.2025.04-04.

[13]

NICHOLSON AG,TSAO MS,BEASLEY MB,et al. The 2021 WHO classification of lung tumors:impact of advances since 2015 [J]. J Thorac Oncol,2022,17 (3):362-387. DOI:10.1016/j.jtho.2021.11.003.

[14]

YI E,LEE JH,JUNG Y,et al. Clinical implication of tumour spread through air spaces in pathological stageⅠlung adenocarcinoma treated with lobectomy [J]. Interact Cardiovasc Thorac Surg,2021,32 (1):64-72. DOI:10.1093/icvts/ivaa227.

[15]

WARTH A,MULEY T,KOSSAKOWSKI CA,et al. Prognostic impact of intra-alveolar tumor spread in pulmonary adenocarcinoma [J]. Am J Surg Pathol,2015,39 (6):793-801. DOI:10.1097/PAS.0000000000000409.

[16]

DU ML,XIN JY,ZHENG R,et al. CYP2A6 activity and cigarette consumption interact in smoking-related lung cancer susceptibility [J]. Cancer Res,2024,84 (4):616-625. DOI:10.1158/0008-5472.CAN-23-0900.

[17]

TOYOKAWA G,YAMADA Y,TAGAWA T,et al. Computed tomography features of resected lung adenocarcinomas with spread through air spaces [J]. J Thorac Cardiovasc Surg,2018,156 (4):1670-1676. e4. DOI:10.1016/j.jtcvs.2018.04.126.

[18]

LEE JH,YOON YC,KIM HS,et al. Obesity is associated with improved postoperative overall survival,independent of skeletal muscle mass in lung adenocarcinoma [J]. J Cachexia Sarcopenia Muscle,2022,13 (2):1076-1086. DOI:10.1002/jcsm.12956.

[19]

OSWALT C,LIU YZ,PANG H,et al. Associations between body mass index,weight loss and overall survival in patients with advanced lung cancer [J]. J Cachexia Sarcopenia Muscle,2022,13 (6):2650-2660. DOI:10.1002/jcsm.13095.

[20]

CARDACI TD,VANDERVEEN BN,BULLARD BM, et al. Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer Cachexia [J]. J Cachexia Sarcopenia Muscle,2024,15 (1):124-137. DOI:10.1002/jcsm.13391.

[21]

ALVAREZ MORENO JC,ALJAMAL AA,BAHMAD HF,et al. Correlation between spread through air spaces (STAS) and other clinicopathological parameters in lung cancer [J]. Pathol Res Pract,2021,220:153376. DOI:10.1016/j.prp.2021.153376.

[22]

TIAN Y,FENG J,JIANG L,et al. Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces [J]. Ann Transl Med,2021,9 (12):985. DOI:10.21037/atm-21-2256.

基金资助

国家自然科学基金(82502484)

AI Summary AI Mindmap
PDF (414KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉